Crystalline Management’s Reunion Neuroscience Inc. Common Shares REUN Stock Holding History

Crystalline Management’s Portfolio REUN Stock Details REUN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-151,253	Closed	-$171K	–	152
2023 Q2	$171K	Buy	+151,253	New	+$128K	0.12%	80

Crystalline Management's REUN Position: Q3 2023 in Review

Crystalline Management sold out of Reunion Neuroscience Inc. Common Shares (REUN) in Q3 2023, closing a stake of 151,253 shares — an estimated $171K sold.

Crystalline Management first reported a position in REUN in Q2 2023 and held it in 1 quarter. The position peaked at $171K in Q2 2023. 0 funds tracked by Wall St. Rank hold REUN as of Q3 2023.

Crystalline Management reported no remaining Reunion Neuroscience Inc. Common Shares position as of Q3 2023 after selling out during the quarter.
Crystalline Management sold 151,253 Reunion Neuroscience Inc. Common Shares shares in Q3 2023, an estimated $171K.
Crystalline Management first reported a position in Reunion Neuroscience Inc. Common Shares in Q2 2023 and held it in 1 quarter.
Crystalline Management's Reunion Neuroscience Inc. Common Shares position peaked at $171K in Q2 2023.
0 funds tracked by Wall St. Rank held Reunion Neuroscience Inc. Common Shares as of Q3 2023.

Based on Crystalline Management's 13F filing for Q3 2023, filed 13 Nov 2023.